12 February 18:00
This event is supported by a Booster Grant from the Oxford Foundry.
Charlotte Casebourne is the CEO of Theolytics, a therapeutics company that spun out of Oxford, while Andrew McLean sits on its board and is also the Head of Life Sciences at Oxford Science Innovation (OSI).
Charlotte and Andy will be running an interactive workshop for those interested in the decision-making process involved in starting a Biotech company. They will present some key points in the company’s history and ask participants to discuss amongst themselves how they might deal with this situation. Andy and Charlotte will then set out how the company acted in that situation.
The interactive nature of the workshop will limit the numbers of participants, so please do sign up as soon as possible to avoid disappointment.
As always, snacks and drinks will be provided.